Dengue Testing Market

Global Market Study on Dengue Testing: Asia Pacific to Hold Dominant Revenue Share over 2017 - 2025

Dengue Testing Market Segmented By Ear, Forehead, Multifunction Measurement Point in Medical, Veterinary

  • April-2018
  • PMRREP22738
  • 240 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Table of Content

1. Executive Summary
     1.1. Market Overview
     1.2. Market Analysis
     1.3. PMR Analysis and Recommendations
     1.4. Wheel of Fortune

2. Market Introduction
     2.1. Market Definition
     2.2. Market Taxonomy

3. Dengue Testing Market Opportunity Analysis
     3.1. Macro-Economic Factors
     3.2. Opportunity Analysis

4. Market Background
     4.1. Evolution of Dengue Testing
     4.2. Market Dynamics
            4.2.1. Drivers
            4.2.2. Restraints
            4.2.3. Opportunity Analysis
     4.3. Regulatory Scenario

5. Macroeconomic Assumptions

6. Key Inclusions
     6.1. Key Manufacturer List
     6.2. Key Mergers & Acquisitions

7. North America Dengue Testing Market Analysis 2012–2016 and Forecast 2017–2025
     7.1. Introduction
     7.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
            7.2.1. U.S.
            7.2.2. Canada
     7.3. Market Size (US$ Mn) Forecast By Country, 2017–2025
     7.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            7.4.1. ELISA-based Tests
            7.4.2. RT-PCR based Tests
            7.4.3. Dengue IgG/IgM Rapid Test
     7.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2025
     7.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
            7.6.1. Hospitals
            7.6.2. Public Health Laboratory
            7.6.3. Diagnostic Centers
            7.6.4. Others
     7.7. Market Size (US$ Mn) Forecast By End User, 2017–2025
     7.8. Drivers and Restraints: Impact Analysis
     7.9. Market Attractiveness Analysis
            7.9.1. By Country
            7.9.2. By Product Type
            7.9.3. By End User
     7.10. Key Market Participants – Intensity Mapping
     7.11. Drivers and Restraints – Impact Analysis

8. Latin America Dengue Testing Market Analysis 2012–2016 and Forecast 2017–2025
     8.1. Introduction
     8.2. Historical Market Size (US$ Mn) Trends Analysis By Country, 2012–2016
            8.2.1. Argentina
            8.2.2. Brazil
            8.2.3. Mexico
            8.2.4. Rest of Latin America
     8.3. Market Size (US$ Mn) Forecast By Country, 2017–2025
     8.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            8.4.1. ELISA-based Tests
            8.4.2. RT-PCR based Tests
            8.4.3. Dengue IgG/IgM Rapid Test
     8.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2025
     8.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
            8.6.1. Hospitals
            8.6.2. Public Health Laboratory
            8.6.3. Diagnostic Centers
            8.6.4. Others
     8.7. Market Size (US$ Mn) Forecast By End User, 2017–2025
     8.8. Drivers and Restraints: Impact Analysis
     8.9. Market Attractiveness Analysis
            8.9.1. By Country
            8.9.2. By Product Type
            8.9.3. By End User
     8.10. Key Market Participants – Intensity Mapping
     8.11. Drivers and Restraints – Impact Analysis

9. Europe Dengue Testing Market Analysis 2012–2016 and Forecast 2017–2025
     9.1. Introduction
     9.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            9.2.1. Germany
            9.2.2. U.K.
            9.2.3. France
            9.2.4. Italy
            9.2.5. Spain
            9.2.6. Russia
            9.2.7. Rest of Europe
     9.3. Market Size (US$ Mn) Forecast By Country, 2017–2025
     9.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            9.4.1. ELISA-based Tests
            9.4.2. RT-PCR based Tests
            9.4.3. Dengue IgG/IgM Rapid Test
     9.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2025
     9.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
            9.6.1. Hospitals
            9.6.2. Public Health Laboratory
            9.6.3. Diagnostic Centers
            9.6.4. Others
     9.7. Market Size (US$ Mn) Forecast By End User, 2017–2025
     9.8. Drivers and Restraints: Impact Analysis
     9.9. Market Attractiveness Analysis
            9.9.1. By Country
            9.9.2. By Product Type
            9.9.3. By End User
     9.10. Key Market Participants – Intensity Mapping
     9.11. Drivers and Restraints – Impact Analysis

10. Asia Pacific Dengue Testing Market Analysis 2012–2016 and Forecast 2017–2025
     10.1.Introduction
     10.2.Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            10.2.1. Japan
            10.2.2. India
            10.2.3. Australia and New Zealand
            10.2.4. Rest of Asia Pacific
     10.3.Market Size (US$ Mn) Forecast By Country, 2017–2025
     10.4.Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            10.4.1. ELISA-based Tests
            10.4.2. RT-PCR based Tests
            10.4.3. Dengue IgG/IgM Rapid Test
     10.5.Market Size (US$ Mn) Forecast By Product Type, 2017–2025
     10.6.Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
            10.6.1. Hospitals
            10.6.2. Public Health Laboratory
            10.6.3. Diagnostic Centers
            10.6.4. Others
     10.7.Market Size (US$ Mn) Forecast By End User, 2017–2025
     10.8. Drivers and Restraints: Impact Analysis
     10.9. Market Attractiveness Analysis
            10.9.1. By Country
            10.9.2. By Product Type
            10.9.3. By End User
     10.10. Key Market Participants – Intensity Mapping
     10.11. Drivers and Restraints – Impact Analysis

11. China Dengue Testing Market Analysis 2012–2016 and Forecast 2017–2025
     11.1.Introduction
     11.2.Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            11.2.1. ELISA-based Tests
            11.2.2. RT-PCR based Tests
            11.2.3. Dengue IgG/IgM Rapid Test
     11.3.Market Size (US$ Mn) Forecast By Product Type, 2017–2025
     11.4.Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
            11.4.1. Hospitals
            11.4.2. Public Health Laboratory
            11.4.3. Diagnostic Centers
            11.4.4. Others
     11.5.Market Size (US$ Mn) Forecast By End User, 2017–2025
     11.6. Drivers and Restraints: Impact Analysis
     11.7. Market Attractiveness Analysis
            11.7.1. By Country
            11.7.2. By Product Type
            11.7.3. By End User
     11.8. Key Market Participants – Intensity Mapping
     11.9. Drivers and Restraints – Impact Analysis

12. Middle East & Africa Dengue Testing Market Analysis 2012–2016 and Forecast 2017–2025
     12.1.Introduction
     12.2.Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            12.2.1. ELISA-based Tests
            12.2.2. RT-PCR based Tests
            12.2.3. Dengue IgG/IgM Rapid Test
     12.3.Market Size (US$ Mn) Forecast By Product Type, 2017–2025
     12.4.Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
            12.4.1. Hospitals
            12.4.2. Public Health Laboratory
            12.4.3. Diagnostic Centers
            12.4.4. Others
     12.5.Market Size (US$ Mn) Forecast By End User, 2017–2025
     12.6. Drivers and Restraints: Impact Analysis
     12.7. Market Attractiveness Analysis
            12.7.1. By Country
            12.7.2. By Product Type
            12.7.3. By End User
     12.8. Key Market Participants – Intensity Mapping
     12.9. Drivers and Restraints – Impact Analysis

13. Forecast Factors: Relevance and Impact

14. Forecast Assumptions

15. Competition Analysis
     15.1.Competition Dashboard
     15.2.Competition Benchmarking
     15.3.Profitability and Gross Margin Analysis By Competition
     15.4.Company Deep Dive
            15.4.1. Thermo Fisher Scientific Inc.
                     15.4.1.1. Overview
                     15.4.1.2. Product  and  Portfolio
                     15.4.1.3. Production Footprint
                     15.4.1.4. Sales Footprint
                     15.4.1.5. Channel Footprint
                     15.4.1.6. Strategy
                                15.4.1.6.1.1. Marketing Strategy
                                15.4.1.6.1.2. Product Strategy
                                15.4.1.6.1.3. Channel Strategy
            15.4.2. Roche Molecular Systems Inc.
                     15.4.2.1. Overview
                     15.4.2.2. Product  and  Portfolio
                     15.4.2.3. Production Footprint
                     15.4.2.4. Sales Footprint
                     15.4.2.5. Channel Footprint
                     15.4.2.6. Strategy
                                15.4.2.6.1.1. Marketing Strategy
                                15.4.2.6.1.2. Product Strategy
                                15.4.2.6.1.3. Channel Strategy
            15.4.3. Abbott Laboratories
                     15.4.3.1. Overview
                     15.4.3.2. Product  and  Portfolio
                     15.4.3.3. Production Footprint
                     15.4.3.4. Sales Footprint
                     15.4.3.5. Channel Footprint
                     15.4.3.6. Strategy
                                15.4.3.6.1.1. Marketing Strategy
                                15.4.3.6.1.2. Product Strategy
                                15.4.3.6.1.3. Channel Strategy
            15.4.4. InBios International, Inc.
                     15.4.4.1. Overview
                     15.4.4.2. Product  and  Portfolio
                     15.4.4.3. Production Footprint
                     15.4.4.4. Sales Footprint
                     15.4.4.5. Channel Footprint
                     15.4.4.6. Strategy
                                15.4.4.6.1.1. Marketing Strategy
                                15.4.4.6.1.2. Product Strategy
                                15.4.4.6.1.3. Channel Strategy
            15.4.5. NovaTec Immundiagnostica GmbH
                     15.4.5.1. Overview
                     15.4.5.2. Product  and  Portfolio
                     15.4.5.3. Production Footprint
                     15.4.5.4. Sales Footprint
                     15.4.5.5. Channel Footprint
                     15.4.5.6. Strategy
                                15.4.5.6.1.1. Marketing Strategy
                                15.4.5.6.1.2. Product Strategy
                                15.4.5.6.1.3. Channel Strategy
            15.4.6. Euroimmun AG (Sub. PerkinElmer)
                     15.4.6.1. Overview
                     15.4.6.2. Product  and  Portfolio
                     15.4.6.3. Production Footprint
                     15.4.6.4. Sales Footprint
                     15.4.6.5. Channel Footprint
                     15.4.6.6. Strategy
                                15.4.6.6.1.1. Marketing Strategy
                                15.4.6.6.1.2. Product Strategy
                                15.4.6.6.1.3. Channel Strategy
            15.4.7. Quest Diagnostics
                     15.4.7.1. Overview
                     15.4.7.2. Product  and  Portfolio
                     15.4.7.3. Production Footprint
                     15.4.7.4. Sales Footprint
                     15.4.7.5. Channel Footprint
                     15.4.7.6. Strategy
                                15.4.7.6.1.1. Marketing Strategy
                                15.4.7.6.1.2. Product Strategy
                                15.4.7.6.1.3. Channel Strategy
            15.4.8. Certest Biotec S.L.
                     15.4.8.1. Overview
                     15.4.8.2. Product  and  Portfolio
                     15.4.8.3. Production Footprint
                     15.4.8.4. Sales Footprint
                     15.4.8.5. Channel Footprint
                     15.4.8.6. Strategy
                                15.4.8.6.1.1. Marketing Strategy
                                15.4.8.6.1.2. Product Strategy
                                15.4.8.6.1.3. Channel Strategy
            15.4.9. OriGene Technologies
                     15.4.9.1. Overview
                     15.4.9.2. Product  and  Portfolio
                     15.4.9.3. Production Footprint
                     15.4.9.4. Sales Footprint
                     15.4.9.5. Channel Footprint
                     15.4.9.6. Strategy
                                15.4.9.6.1.1. Marketing Strategy
                                15.4.9.6.1.2. Product Strategy
                                15.4.9.6.1.3. Channel Strategy
            15.4.10. Abnova Corporation
                     15.4.10.1. Overview
                     15.4.10.2. Product  and  Portfolio
                     15.4.10.3. Production Footprint
                     15.4.10.4. Sales Footprint
                     15.4.10.5. Channel Footprint
                     15.4.10.6. Strategy
                                15.4.10.6.1.1. Marketing Strategy
                                15.4.10.6.1.2. Product Strategy
                                15.4.10.6.1.3. Channel Strategy

16. Global Dengue Testing Market Analysis 2012–2016 and Forecast 2017–2025, By Region
     16.1. Introduction/Key Findings
     16.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
     16.3. Market Size (US$ Mn) Forecast By Region, 2017–2025
            16.3.1. North America
            16.3.2. Latin America
            16.3.3. Europe
            16.3.4. Asia Pacific
            16.3.5. Middle East & Africa
            16.3.6. China
     16.4.Market Attractiveness Analysis By Region

17. Global Dengue Testing Analysis 2012–2016 and Forecast 2017–2025, By Product Type
     17.1. Introduction/Key Findings
     17.2.Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            17.2.1. ELISA-based Tests
            17.2.2. RT-PCR based Tests
            17.2.3. Dengue IgG/IgM Rapid Test
     17.3.Market Size (US$ Mn) Forecast By Product Type, 2017–2025
     17.4.Market Attractiveness Analysis By Product Type

18. Global Dengue Testing  Market Analysis 2012–2016 and Forecast 2017–2025, By End User
     18.1. Introduction/Key Findings
     18.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
            18.2.1. Hospitals
            18.2.2. Public Health Laboratory
            18.2.3. Diagnostic Centers
            18.2.4. Others
     18.3.Market Size (US$ Mn) Forecast By End User, 2017–2025
     18.4.Market Attractiveness Analysis By End User

19. Global Dengue Testing  Market Analysis 2012–2016 and Forecast 2017–2025
     19.1. Market Value Share Analysis By All Segment
     19.2. Y-o-Y Growth Analysis By All Segment
     19.3. Absolute $ Opportunity

Find Out More about the Report Coverage

List of Tables

List of Table

Table 01: North America Dengue Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Country
Table 02: North America Dengue Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Product Type
Table 03: North America Dengue Testing Market Volume ('000 units)  Analysis-2012–2016 and Forecast 2017–2025, By Product Type
Table 04: North America Dengue Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User
Table 05: Latin America Dengue Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Country
Table 06: Latin America Dengue Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Product Type
Table 07: Latin America Dengue Testing Market Volume ('000 units)  Analysis-2012–2016 and Forecast 2017–2025, By Product Type
Table 08: Latin America Dengue Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User
Table 09: Europe Dengue Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Country
Table 10: Europe Dengue Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Product Type
Table 11: Europe Dengue Testing Market Volume ('000 units)  Analysis-2012–2016 and Forecast 2017–2025, By Product Type
Table 12: Europe Dengue Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User
Table 13: APAC Dengue Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Country
Table 14: APAC Dengue Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Product Type
Table 15: APAC Dengue Testing Market Volume ('000 units)  Analysis-2012–2016 and Forecast 2017–2025, By Product Type
Table 16: APAC Dengue Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User
Table 17: China Dengue Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Product Type
Table 18: China Dengue Testing Market Volume ('000 units)  Analysis-2012–2016 and Forecast 2017–2025, By Product Type
Table 19: China Dengue Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User
Table 20: MEA Dengue Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Country
Table 21: MEA Dengue Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By Product Type
Table 22: MEA Dengue Testing Market Volume ('000 units)  Analysis-2012–2016 and Forecast 2017–2025, By Product Type
Table 23: MEA Dengue Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2025, By End User
Table 24: Global Dengue Testing Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Region 
Table 25: Global Dengue Testing Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Product Type 
Table 26: Global Dengue Testing Market Volume ('000 units)  2012–2016 and Forecast 2017-2025 By Product Type 
Table 27: Global Dengue Testing Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By End User

Explore Persistence Market Research’s expertise in promulgation of the business !

List of Chart

List Of Figure

Figure 01: Dengue Testing Market Revenue Share by Product Type, 2017E & 2025F
Figure 02: Dengue Testing Market Revenue Share by End User, 2017E & 2025F
Figure 03: Dengue Testing Market Revenue Share by Region, 2017E & 2025F
Figure 04: North America Dengue Testing Market Revenue Share by Product Type, 2017E & 2025F
Figure 05: North America Dengue Testing Market Revenue Share by End User, 2017E & 2025F
Figure 06: North America Dengue Testing Market Revenue Share by Country, 2017E & 2025F
Figure 07: North America Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 08: North America Dengue Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 09: U.S. Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 10: U.S. Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 11: Canada Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 12: Canada Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 13: North America ELISA-based Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 14: North America ELISA-based Tests Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 15: North America RT-PCR based Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 16: North America RT-PCR based Tests Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 17: North America Dengue IgG/IgM Rapid Test Market Size (US$ Mn) Analysis, 2012–2016
Figure 18: North America Dengue IgG/IgM Rapid Test Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 19: North America Dengue Testing Market Attractiveness Analysis, By Product Type
Figure 20: North America Dengue Testing Market Attractiveness Analysis, By End User
Figure 21: North America Dengue Testing Market Attractiveness Analysis, By Country
Figure 22: Latin America Dengue Testing Market Revenue Share by Product Type, 2017E & 2025F
Figure 23: Latin America Dengue Testing Market Revenue Share by End User, 2017E & 2025F
Figure 24: Latin America Dengue Testing Market Revenue Share by Country, 2017E & 2025F
Figure 25: Latin America Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 26: Latin America Dengue Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 31: Brazil Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 32: Brazil Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 33: Argentina Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 34: Argentina Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 35: Mexico Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 36: Mexico Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 37: Rest of Latin America Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 38: Rest of Latin America Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 39: Latin America ELISA-based Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 40: Latin America ELISA-based Tests Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 41: Latin America RT-PCR based Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 42: Latin America RT-PCR based Tests Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 43: Latin America Dengue IgG/IgM Rapid Test Market Size (US$ Mn) Analysis, 2012–2016
Figure 44: Latin America Dengue IgG/IgM Rapid Test Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 45: Latin America Dengue Testing Market Attractiveness Analysis, By Product Type
Figure 46: Latin America Dengue Testing Market Attractiveness Analysis, By End User
Figure 47: Latin America Dengue Testing Market Attractiveness Analysis, By Country
Figure 48: Europe Dengue Testing Market Revenue Share by Product Type, 2017E & 2025F
Figure 49: Europe Dengue Testing Market Revenue Share by End User, 2017E & 2025F
Figure 50: Europe Dengue Testing Market Revenue Share by Country, 2017E & 2025F
Figure 51: Europe Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 52: Europe Dengue Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 53: Germany Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 54: Germany Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 55: Russia Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 56: Russia Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 57: U.K. Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 58: U.K. Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 59: France Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 60: France Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 61: Italy Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 62: Italy Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 63: Spain Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 64: Spain Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 65: Rest of Europe Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 66: Rest of Europe Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 67: Europe ELISA-based Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 68: Europe ELISA-based Tests Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 69: Europe RT-PCR based Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 70: Europe RT-PCR based Tests Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 71: Europe Dengue IgG/IgM Rapid Test Market Size (US$ Mn) Analysis, 2012–2016
Figure 72: Europe Dengue IgG/IgM Rapid Test Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 73: Europe Dengue Testing Market Attractiveness Analysis, By Product Type
Figure 74: Europe Dengue Testing Market Attractiveness Analysis, By End User
Figure 75: Europe Dengue Testing Market Attractiveness Analysis, By Country
Figure 76: APAC Dengue Testing Market Revenue Share by Product Type, 2017E & 2025F
Figure 77: APAC Dengue Testing Market Revenue Share by End User, 2017E & 2025F
Figure 78: APAC Dengue Testing Market Revenue Share by Country, 2017E & 2025F
Figure 79: APAC Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 80: APAC Dengue Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 81: India Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 82: India Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 83: Japan Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 84: Japan Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 85: ASEAN Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 86: ASEAN Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 87: Australia and New Zealand Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 88: Australia and New Zealand Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 89: Rest of APAC Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 90: Rest of APAC Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 91: APAC ELISA-based Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 92: APAC ELISA-based Tests Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 93: APAC RT-PCR based Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 94: APAC RT-PCR based Tests Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 95: APAC Dengue IgG/IgM Rapid Test Market Size (US$ Mn) Analysis, 2012–2016
Figure 96: APAC Dengue IgG/IgM Rapid Test Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 97: APAC Dengue Testing Market Attractiveness Analysis, By Product Type
Figure 98: APAC Dengue Testing Market Attractiveness Analysis, By End User
Figure 99: APAC Dengue Testing Market Attractiveness Analysis, By Country
Figure 100: China Dengue Testing Market Revenue Share by Product Type, 2017E & 2025F
Figure 101: China Dengue Testing Market Revenue Share by End User, 2017E & 2025F
Figure 102: China Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 103: China Dengue Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 104: China ELISA-based Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 105: China ELISA-based Tests Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 106: China RT-PCR based Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 107: China RT-PCR based Tests Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 108: China Dengue IgG/IgM Rapid Test Market Size (US$ Mn) Analysis, 2012–2016
Figure 109: China Dengue IgG/IgM Rapid Test Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 110: China Dengue Testing Market Attractiveness Analysis, By Product Type
Figure 111: China Dengue Testing Market Attractiveness Analysis, By End User
Figure 112: MEA Dengue Testing Market Revenue Share by Product Type, 2017E & 2025F
Figure 113: MEA Dengue Testing Market Revenue Share by End User, 2017E & 2025F
Figure 114: MEA Dengue Testing Market Revenue Share by Country, 2017E & 2025F
Figure 115: MEA Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 116: MEA Dengue Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 117: GCC Countries Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 118: GCC Countries Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 119: South Africa Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 120: South Africa Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 121: Rest of MEA Dengue Testing Market Size (US$ Mn) Analysis, 2012–2016
Figure 122: Rest of MEA Dengue Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 123: MEA ELISA-based Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 124: MEA ELISA-based Tests Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 125: MEA RT-PCR based Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 126: MEA RT-PCR based Tests Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 127: MEA Dengue IgG/IgM Rapid Test Market Size (US$ Mn) Analysis, 2012–2016
Figure 128: MEA Dengue IgG/IgM Rapid Test Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 129: MEA Dengue Testing Market Attractiveness Analysis, By Product Type
Figure 130: MEA Dengue Testing Market Attractiveness Analysis, By End User
Figure 131: MEA Dengue Testing Market Attractiveness Analysis, By Country
Figure 132: Global Dengue Testing Market Share Analysis (%) By Region, 2017 & 2025
Figure 133: Global Dengue Testing Market Y-o-Y Growth (%) By Region, 2017–2025
Figure 134: Global Dengue Testing Market Attractiveness Analysis By Region, 2017–2025
Figure 135: Global Dengue Testing Market Share Analysis (%) By Product Type, 2017 & 2025
Figure 136: Global Dengue Testing Market Y-o-Y Growth (%) By Product Type, 2017–2025
Figure 137: Global Dengue Testing Market Attractiveness Analysis By Product Type, 2017–2025
Figure 138: Global Dengue Testing Market Share Analysis (%) By End User, 2017 & 2025
Figure 139: Global Dengue Testing Market Y-o-Y Growth (%) By End User, 2017–2025
Figure 140: Global Dengue Testing Market Attractiveness Analysis By End User, 2017–2025
Figure 141: Global Dengue Testing Market Value Analysis and Forecast, 2016–2025 (US$ Mn)
Figure 142: Global Dengue Testing Market Value (US$ Mn), 2012–2016
Figure 143: Global Dengue Testing Market Absolute $ Opportunity (US$ Mn), 2016–2025

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Description

Overview of the global dengue testing market with reference to the global healthcare services market

There is growing consensus among healthcare providers that the current fee-for-services payment mechanism needs an overhaul. While fee-for-services is the pervasive method of billing patients, alternative processes, such as capitation and pay-for-performance are also being considered. We anticipate fee-for-services to be supplemented by capitation and pay-for-performance in the future. In addition to charging patients for screening and doctor visits, pay-for-performance can lead to higher quality of care, as other essential tasks will also be billed. It may lead to an increase in healthcare costs, with the promise that quality of care will go up.

The healthcare system is in a phase where access to capital is constantly diminishing. Big spends are rare and there is increasing uncertainty among borrowers about their ability to repay loans and funding. Healthcare institutions are either postponing large capital-intensive projects or allocating resources to specialty areas that offer a high ROI. Cash-constraints will result into an increase in mergers and acquisitions and lead to fundraising from healthcare providers. However, as only a select few will qualify for an acquisition or funding, the effects of cash-crunch will be palpable in this sector.

Healthcare providers and insurers are aware of the rapidly increasingly population and their growing healthcare needs. The impact is more palpable in the U.S. and Japan – important markets in terms of their standing in the global healthcare market. Providers and insurers are strategizing to tap into the available opportunities in this demographic. Baby boomers around the globe are actively taking charge of their health. Smartphone remains the primary source of information-seeking for this segment. With over 70,000 websites and hundreds of apps disseminating information, providers and insurers will focus on strengthening their digital presence to effectively target this demographic.

Healthcare providers and insurers are aware that emerging markets remain crucial to their long-term prospects. In a bid to consolidate their position in key emerging markets, such as China and India, leading healthcare providers and pharma companies are opening up new facilities and partnering with local players. Spending on healthcare services is expected to grow at a higher pace in Asia Pacific, owing to the rise of a strong middle class. We anticipated key players to increase their investment in emerging markets in the future.

Parent Indicators Healthcare

  • Current expenditure on health, % of gross domestic product
  • Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)
  • Annual growth rate of current expenditure on health, per capita, in real terms
  • Out-of-pocket expenditure, % of current expenditure on healthcare services
  • Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)
  • Physicians, Density per 1000 population (head counts)
  • Nurses, Density per 1000 population (head counts)

Research Methodology

Persistence Market Research utilizes robust methodology and approach to arrive at market size and related projections. The research methodology for this report is based on 3 dimensional model. We conduct about 45-60 min duration detailed interviews with product manufacturers; apart from this we also collect market feedback from industry experts. To validate this data, we interact with senior panel members having more than 10 years of experience in relevant field. The panel members help in validating the findings and fill the gaps if any.  In addition, we leverage on our existing pool of information, paid database and other valid information sources available in public domain. Usually industry interactions extend to more than 50+ interviews from market participants across the value chain.

Data Collection

Persistence Market Research collects data from secondary sources including company annual reports_bk_01_01_2020, association publications, industry presentations, white papers, and company press releases. Apart from these we leverage over paid database subscriptions and industry magazines to collect market information and developments in exhaustive manner. After being done with desk research, detailed questionnaire and discussion guide is formulated to initiate primary research with key industry personnel; the discussion aims at collecting key insights, growth perspectives, prevalent market trends and quantitative insights including market size and competition developments. Both of these research approaches help us in arriving at base year numbers and market hypothesis.

Data Validation

In this phase, Persistence Market Research validates the data using macro and micro economic factors. For instance, growth in electricity consumption, industry value added, other industry factors, economic performance, growth of top players and sector performance is closely studied to arrive at precise estimates and refine anomalies if any.

Data Analysis and Projection

Data analysis and projections were made based on proprietary research frameworks and statistical analysis, which was further validated from industry participants. These frameworks include Y-o-Y growth projections, macro-economic factor performance, market attractiveness analysis, key financial ratios, and others.

For public companies we capture the data from company website, annual reports_bk_01_01_2020, investor presentations, paid databases. While for privately held companies, we try to gather information from the paid databases (like Factiva) and based on the information we gather from databases we estimate revenue for the companies. In addition, the team tries to establish primary contact with the companies in order to validate the assumptions or to gather quality inputs.

Standard Report Structure

  • Executive Summary
  • Market Definition
  • Macro-economic analysis
  • Parent Market Analysis
  • Market Overview
  • Forecast Factors
  • Segmental Analysis and Forecast
  • Regional Analysis
  • Competition Analysis

Target Audience

  • Physicians
  • Surgeons
  • Pathology In charge
  • Procurement Manager
  • Laboratory Technicians
  • Hospital Accountants
  • Independent Consultants
  • Government Authorities

Recommendations

Polyol Ester Market

As per PMR's research study, global polyol ester market anticipated to rise at a robust CAGR of 5.1% along with a healthy revenue during the forecast period of 2017-2027.

White Spirit Market

White Spirits Market are of four types - Type 1, Type 2, Type 3, and Type 0, which are categorized on their aromatic content basis. White spirits are consumed in a wide range of applications such as paint thinners, cleaning solvents, degreasing solvents, fuels, and disinfectants, among others..

Dearomatic Solvents Market

The global de-aromatic solvents market is estimated to expand at a CAGR of more than 6% over the forecast period of 2021-2031..

Asia Pacific North America Europe Fluorinated Solvents Market

The Asia Pacific Fluorinated Solvents market is expected to register a CAGR of 9.0% over the forecast period (2018–2026)..

Our Clients

Our Clients